CN105902524A — 一种酒石酸唑吡坦舌下膜及其制备方法
Assigned to Hefei Huafang Pharmaceutical Sciences & Technology Co Ltd · Expires 2016-08-31 · 10y expired
What this patent protects
本发明公开了一种酒石酸唑吡坦舌下膜及其制备方法,属于制药制剂领域。该酒石酸唑吡坦舌下膜由酒石酸唑吡坦、高分子成膜材料、增塑剂、促渗剂、矫味剂和其它辅料组成;加入促渗剂后,主药透过动物体外舌下粘膜的速率明显增加。该剂型的特点是崩解迅速,无需水送服且服药顺应性好,优于大部分口服固体制剂,尤其适用于吞咽困难、老人和儿童等人群。
USPTO Abstract
本发明公开了一种酒石酸唑吡坦舌下膜及其制备方法,属于制药制剂领域。该酒石酸唑吡坦舌下膜由酒石酸唑吡坦、高分子成膜材料、增塑剂、促渗剂、矫味剂和其它辅料组成;加入促渗剂后,主药透过动物体外舌下粘膜的速率明显增加。该剂型的特点是崩解迅速,无需水送服且服药顺应性好,优于大部分口服固体制剂,尤其适用于吞咽困难、老人和儿童等人群。
Drugs covered by this patent
- Viagra (Sildenafil Citrate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.